Factors linked to C difficile infection in patients with IBD include IBD activity prior to infection, shorter disease ...

Tampa Bay Lightning forward Michael Eyssimont was diagnosed with Crohn's disease eight years ago at the age of 21. Since then ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Extraintestinal manifestations and arthralgia are significant predictors of IBD-related arthritis among patients with CD, while sacroiliitis was not associated.

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

A study has shown how data, collected by wearable technology, can identify disease flare-ups up to seven weeks in advance.

An international team led by researchers at the University of Toronto has found a compound in ginger, called furanodienone ...

CJ Bioscience announced today that it will present preclinical data on its novel drug candidate CJRB-201 at the European ...

Inflammatory bowel disease (IBD) affects between 2.4 and 3.1 million people across the United States, according to the ...